Featured Insights
February 9, 2026
Newsletter
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law.
February 5, 2026
Client Alert
DOJ rewarded $1 million to a whistleblower for providing information about a criminal antitrust conspiracy.
February 5, 2026
Report
In this report, we explore how MiFID II inducements requirements apply to firms and their counterparties in common scenarios.